| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 11/11/2003 | CA2056279C Cell-free receptor binding assays, the production and use thereof |
| 11/10/2003 | CA2428482A1 Multilayer reagent test strips and methods for using the same to quantify glycated protein in a physiological sample |
| 11/07/2003 | CA2385194A1 Method of diagnosis and treatment for affective disorders |
| 11/06/2003 | WO2003091835A2 Computationally targeted evolutionary design |
| 11/06/2003 | WO2003091734A1 Diagnostic and therapeutic use of ensadin-0477 gene and protein for neurodegenerative diseases |
| 11/06/2003 | WO2003091733A1 Method of judging the onset risk of arteriosclerosis and arteriosclerotic complication |
| 11/06/2003 | WO2003091730A1 Device and method for monitoring leukocyte migration |
| 11/06/2003 | WO2003091729A1 Bio-spectral imaging system and methods for diagnosing cell disease state |
| 11/06/2003 | WO2003091717A1 Systems and methods for blood glucose sensing |
| 11/06/2003 | WO2003091701A2 Implantable biosensor from stratified nanostructured membranes |
| 11/06/2003 | WO2003091698A2 Cetp genetic markers for statin-specific changes in hdl cholesterol |
| 11/06/2003 | WO2003091696A2 Process for identifying and treating specified cell types |
| 11/06/2003 | WO2003091695A2 Identification of biomarkers for detecting prostate cancer |
| 11/06/2003 | WO2003091692A2 Methods for evaluation of in vitro aminoacyl trna production using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry |
| 11/06/2003 | WO2003091690A2 Cancer-associated nucleic acids and polypeptides |
| 11/06/2003 | WO2003091459A1 Cells for detection of influenza and parainfluenza viruses |
| 11/06/2003 | WO2003091458A1 Integrated nanomechanical sensor array chips |
| 11/06/2003 | WO2003091457A1 Method for determining the presence of dna variants using peptide nucleic acid probes |
| 11/06/2003 | WO2003091456A1 A dna enzyme to inhibit plasminogen activator inhibitor-1 |
| 11/06/2003 | WO2003091455A1 Compositions and methods related to two-arm nucleic acid probes |
| 11/06/2003 | WO2003091454A1 Haplotypes of the aldob gene |
| 11/06/2003 | WO2003091453A1 Haplotypes of the hcf2 gene |
| 11/06/2003 | WO2003091452A1 Isolating nucleic acid |
| 11/06/2003 | WO2003091451A1 Diagnostic and therapeutic use of ensadin-0138 gene and protein for neurodegenerative diseases |
| 11/06/2003 | WO2003091450A1 Method for evaluating a therapeutic potential of a chemical entity |
| 11/06/2003 | WO2003091449A1 Method of measuring neprilysin activity |
| 11/06/2003 | WO2003091446A2 Multi-functional microarrays and methods |
| 11/06/2003 | WO2003091439A1 Reporter-selectable hepatitis c virus replicon |
| 11/06/2003 | WO2003091427A1 Kidney disease-associated genes expressed in proximal tubule |
| 11/06/2003 | WO2003091426A1 Compilations of nucleic acids and arrays and methods of using them |
| 11/06/2003 | WO2003091418A2 Novel essential fungal polynucleotides, polypeptides, and methods of use |
| 11/06/2003 | WO2003091417A2 Self-similar ordered microstructural arrays of amphiphilic molecules |
| 11/06/2003 | WO2003091416A2 Constant length signatures for parallel sequencing of polynucleotides |
| 11/06/2003 | WO2003091415A2 Fluorobodies and chromobodies: binding ligands with intrinsic fluorescence and color |
| 11/06/2003 | WO2003091413A2 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same |
| 11/06/2003 | WO2003091410A2 Method of fingerprinting tissue samples |
| 11/06/2003 | WO2003091408A2 Characterization of single stranded nucleic acids by melting analysis using a double strand specific nucleic acid dye |
| 11/06/2003 | WO2003091407A2 Device and method for high-throughput quantification of mrna from whole blood |
| 11/06/2003 | WO2003091406A2 Amplification of dna to produce single-stranded product of defined sequence and length |
| 11/06/2003 | WO2003091404A2 Formation and use of site specific nucleic acid coupled binding polypeptides |
| 11/06/2003 | WO2003091402A2 N-ACETYLGLUCOSAMINYLTRANSFERASE Vb CODING SEQUENCE, RECOMBINANT CELLS AND METHODS |
| 11/06/2003 | WO2003091399A2 Production and use of salt tolerant and culture density tolerant organisms |
| 11/06/2003 | WO2003091391A2 Atherosclerotic phenotype determinative genes and methods for using the same |
| 11/06/2003 | WO2003091390A2 Regulation of gene expression by neuromodulators and discovery of a novel ngf-induced protein termed pincher |
| 11/06/2003 | WO2003091388A2 Polymorphic olfactory receptor genes and arrays, kits and methods utilizing them |
| 11/06/2003 | WO2003091386A2 A new family of picornaviruses |
| 11/06/2003 | WO2003091382A2 Dna authentication based on scattered-light detection |
| 11/06/2003 | WO2003091381A2 Height-related gene |
| 11/06/2003 | WO2003091277A2 Haplotypes of the cetp gene |
| 11/06/2003 | WO2003091270A1 Mouse hepatitis virus detection |
| 11/06/2003 | WO2003091269A1 A gene abnormally expressed in autoimmune diseases and malignancies |
| 11/06/2003 | WO2003091268A1 Molecular interaction sites of vimentin rna and methods of modulating the same |
| 11/06/2003 | WO2003091264A2 Non nucleoside reverse transcriptase inhibitors |
| 11/06/2003 | WO2003091225A1 Substituted pyrazine derivatives |
| 11/06/2003 | WO2003090780A1 Direct cell target analysis |
| 11/06/2003 | WO2003090774A1 Mannose binding lectin and uses thereof |
| 11/06/2003 | WO2003090695A2 TREATMENT OF α-GALACTOSIDASE A DEFICIENCY |
| 11/06/2003 | WO2003090694A2 Methods and compositions for diagnosing and monitoring auto immune and chronic inflammatory diseases |
| 11/06/2003 | WO2003090691A2 Method and compositions for identifying anti-hiv therapeutic compounds |
| 11/06/2003 | WO2003090690A2 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such |
| 11/06/2003 | WO2003090685A2 Methods for stimulating tlr/irf3 pathways for inducing anti-microbial, anti-inflammatory and anticancer responses |
| 11/06/2003 | WO2003090515A2 Systems and methods for detection of nuclear receptor function using reporter enzyme mutant complementation |
| 11/06/2003 | WO2003090512A2 Regeneration of endogenous myocardial tissue by induction of neovascularization |
| 11/06/2003 | WO2003081249A3 Method for the detection of prion proteins |
| 11/06/2003 | WO2003072822A9 Mononucleotide repeats microsatellite markers for detecting microsatellite instability. |
| 11/06/2003 | WO2003070964A3 Methods for searching polynucleotide probe targets in databases |
| 11/06/2003 | WO2003070898A3 Selective extraction of dna from groups of cells |
| 11/06/2003 | WO2003070171A3 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells |
| 11/06/2003 | WO2003066889A3 Assay for acytyltransferase or deacetylase activity |
| 11/06/2003 | WO2003060156A3 Dna detection using primers hybridizing to non-fragmentated dna |
| 11/06/2003 | WO2003060073A3 An in vivo protein screen based on enzyme-assisted chemically induced dimerization ('cid') |
| 11/06/2003 | WO2003057927A3 Detection of human papillomavirus e6 mrna |
| 11/06/2003 | WO2003057839A3 Compositions and methods relating to urinary specific genes and proteins |
| 11/06/2003 | WO2003057007A3 System for monitoring bacterial tumor treatment |
| 11/06/2003 | WO2003056342A3 Method for determining molecule-molecule interaction in proteomics |
| 11/06/2003 | WO2003054541A3 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
| 11/06/2003 | WO2003054149A3 Targeted genetic risk-stratification using microarrays |
| 11/06/2003 | WO2003054139A3 Compositions and methods utilizing dna polymerases |
| 11/06/2003 | WO2003053535B1 Nanoparticle imaging system and method |
| 11/06/2003 | WO2003052380A3 Recruitment of mst1 or mst2 protein kinase to induce apoptosis in eukaryotic cells |
| 11/06/2003 | WO2003052124A3 Screening method for agents useful in treating diabetes |
| 11/06/2003 | WO2003048378A3 Methods and compositions for selectively cleaving dna containing duplex acids in a complex nucleic acid mixture |
| 11/06/2003 | WO2003043402A3 Nucleic acid probes and methods to detect and/or quantify nucleic acid analytes |
| 11/06/2003 | WO2003040395A3 Universal nucleotides for nucleic acid analysis |
| 11/06/2003 | WO2003031939A3 Protein modification and maintenance molecules |
| 11/06/2003 | WO2003029402A3 Unique properties of stem cells |
| 11/06/2003 | WO2003028627A3 Method for detecting procoagulant conditions |
| 11/06/2003 | WO2003027638A3 Methods for detecting genetic mosaicisms using arrays |
| 11/06/2003 | WO2003027307A3 Nucleic acid sequencing by raman monitoring of uptake of precursors during molecular replication |
| 11/06/2003 | WO2003027263A3 Proteins associated with cell growth, differentiation, and death |
| 11/06/2003 | WO2003027237A3 Method of modulating or examining ku70 levels in cells |
| 11/06/2003 | WO2003020922A3 Enzymes involved in cell wall biosynthesis in filamentous fungi |
| 11/06/2003 | WO2003019138A3 Bio-sensing platforms for detection and quantitation of biological molecules |
| 11/06/2003 | WO2003018749A3 Compositions and methods for generating antigen-binding units |
| 11/06/2003 | WO2003018745A3 Method of screening for drug hypersensitivity reaction |
| 11/06/2003 | WO2003016568A3 Yeast arrays, methods of making such arrays, and methods of analyzing such arrays |
| 11/06/2003 | WO2003016354A3 Recombinant anti-plasmodium falciparum antibodies |
| 11/06/2003 | WO2003014744A3 Method and diagnostic kit for diagnosing helicobacter pylori |
| 11/06/2003 | WO2003014392A3 Use and evaluation of a [2+2] photoaddition in immobilization of oligonucleotides on a three-dimensional hydrogel matrix |
| 11/06/2003 | WO2003014388A3 Method and nucleic acids for the analysis of colon cancer |